COLLABORATION AND LICENSE AGREEMENT BY AND AMONG LEGEND BIOTECH USA, INC., LEGEND BIOTECH IRELAND LIMITED AND JANSSEN BIOTECH, INC.Collaboration and License Agreement • May 13th, 2020 • Legend Biotech Corp • Pharmaceutical preparations • New York
This Collaboration and License Agreement (the “Agreement”) is made and effective as of December 21, 2017 (the “Effective Date”) by and among Legend Biotech USA, Inc., a Delaware corporation (“Legend U.S.”), Legend Biotech Ireland Limited, an Irish entity (“Legend Ireland”; together with Legend U.S., “Legend”) and Janssen Biotech, Inc., a Pennsylvania corporation (“Janssen”).
COLLABORATIVE RESEARCH AND LICENSE AGREEMENT BY AND BETWEEN NOILE-IMMUNE BIOTECH, INC. AND LEGEND BIOTECH USA, INC. April 27, 2020Collaborative Research and License Agreement • May 13th, 2020 • Legend Biotech Corp • Pharmaceutical preparations
THIS COLLABORATIVE RESEARCH AND LICENSE AGREEMENT (this “Agreement”) is made as of April __, 2020 (the “Effective Date”) by and between Noile-Immune Biotech, Inc., a Japanese corporation having its principal place of business at 2-12-10 Shiba-Daimon, Minato-ku, Tokyo 105-0012, Japan (“Noile”), and Legend Biotech USA, Inc., a company incorporated under the laws of New York having its principal place of business at 10 Knightsbridge Road, Piscataway, NJ 08854, USA (“Legend”). Noile and Legend are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
EMPLOYMENT CONTRACT FOR CHIEF EXECUTIVE OFFICEREmployment Agreement • May 13th, 2020 • Legend Biotech Corp • Pharmaceutical preparations • New Jersey
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is executed on the 28th day of March 2018 by and between Legend Biotech USA Inc. (hereinafter referred to as “Employer” or “Legend Biotech”) with a business address of 860 Centennial Ave, Piscataway, NJ 08854 and Yuan Xu, residing at 403 Country Club Drive, Apt 101, Simi Valley, CA 93065 (hereinafter referred to as “Employee”).
LEGEND BIOTECH CORPORATION INVESTORS’ RIGHTS AGREEMENT MARCH 30, 2020Investors’ Rights Agreement • May 13th, 2020 • Legend Biotech Corp • Pharmaceutical preparations • New York
THIS INVESTORS’ RIGHTS AGREEMENT is made as of March 30, 2020, by and among Legend Biotech Corporation, a Cayman Islands exempted company (the “Company”), and each of the investors listed on Schedule A hereto (each an “Investor” and collectively the “Investors”).
LEASE AGREEMENTLease Agreement • May 13th, 2020 • Legend Biotech Corp • Pharmaceutical preparations • New Jersey
This LEASE AGREEMENT (this “Lease”) is dated February 8, 2018 and is between GENSCRIPT USA HOLDING, INC. (“Landlord”), and LEGEND BIOTECH USA INC. (“Tenant”).
